Welcome to our dedicated page for Amphenol SEC filings (Ticker: APH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Amphenol Corporation (NYSE: APH) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret complex documents. Amphenol uses Form 8-K current reports extensively to announce material events, including acquisitions, financing arrangements and governance changes.
Recent APH filings include Form 8-K reports detailing the completion of the acquisition of CommScope’s Connectivity and Cable Solutions business for approximately $10.5 billion in cash, the entry into three-year and 364-day unsecured delayed draw term loan credit agreements intended to help finance that acquisition, and the issuance of multiple series of senior notes with maturities ranging from 2027 to 2055. Other 8-Ks cover topics such as quarterly financial results, the acquisition of Trexon, the acquisition of Rochester Sensors, and the appointment of Sanjiv Lamba to Amphenol’s board of directors.
On this page, you can review Amphenol’s current reports on Form 8-K, as well as its annual reports on Form 10-K, quarterly reports on Form 10-Q and other registered securities documents when available. These filings provide insight into Amphenol’s interconnect, sensor and cable businesses, its capital structure, and its acquisition and financing strategies.
Stock Titan enhances these documents with AI-powered summaries that highlight key terms, such as acquisition consideration, financing amounts, segment classification for acquired businesses, and significant changes in governance or capital markets activity. Users can also quickly locate information about Amphenol’s registered securities, including its Class A common stock and listed senior notes, and monitor new filings as they are posted to EDGAR.
For investors analyzing APH stock, this filings page offers a structured way to review Amphenol’s regulatory history, understand the details behind major transactions like the CCS acquisition and Trexon purchase, and see how the company discloses risks, non-GAAP measures and other important information in its SEC reports.
Amphenol Corporation (APH) reported insider derivative transactions by its Senior Vice President of Human Resources on a Form 4. The filing shows stock options on Class A common stock with exercise prices of $37.9 and $65.955 tied to multiple grants. Following the reported transactions dated 11/13/2025, the officer holds option positions both directly and indirectly through the Silverman Family Trust, including option grants over 29,012 and 18,343 underlying shares. These changes reflect reallocation of beneficial ownership between direct and trust accounts rather than new equity issuance by the company.
Amphenol (APH) disclosed insider transactions by its Senior VP & CFO on 11/11/2025. The reporting person exercised 300,000 stock options at $21.995 per share and sold 258,000 Class A shares at a weighted average price of $143.2022. Separately, the Lampo Family Trust exercised 40,076 options at $21.995 and sold 40,076 shares at a weighted average price of $143.5015.
Following these transactions, directly held Class A shares were 167,695. Indirect holdings included 39,884 by the Lampo Family Trust, 58,116 by the Craig A. Lampo 2025 GRAT #1, 74,305 by the 2024 GRAT #1, and 160,000 by the 2024 GRAT #2. Derivative holdings listed 100,000 stock options directly after the reported activity. Prices reflect weighted averages, with trades executed in multiple lots as noted.
APH: A shareholder filed a Form 144 notice to sell up to 258,000 shares of Common stock through Morgan Stanley Smith Barney LLC Executive Financial Services. The filing lists an aggregate market value of $36,946,167.60 and an approximate sale date of 11/11/2025 on the NYSE.
The shares to be sold were acquired on 11/11/2025 via exercise of options under a registered plan, paid in cash. Shares outstanding were 1,224,055,508. In the prior three months, disclosed sales included 199,848 shares by Craig Lampo for $22,069,674.29 and 40,076 shares by the Lampo Family Trust for $4,430,602.18.
Amphenol (APH) received a Form 144 notice for a proposed sale of 40,076 shares of common stock through Morgan Stanley Smith Barney. The filing lists an aggregate market value of $5,750,966.11, an approximate sale date of 11/11/2025, and the NYSE as the exchange.
The shares to be sold were acquired on 11/11/2025 via the exercise of options under a registered plan for cash. Shares outstanding are reported as 1,224,055,508; this is a baseline figure, not the amount being sold. Recent sales disclosed for related accounts in the past three months include the Lampo Family Trust 40,076 shares on 08/25/2025 for $4,430,602.18 and Craig Lampo 199,848 shares on 08/22/2025 for $22,069,674.29.
Amphenol Corporation issued and sold multiple senior notes in an underwritten public offering, including Floating Rate Notes due 2027 and fixed‑rate series at 3.800% (2027), 3.900% (2028), 4.125% (2030), 4.400% (2033), 4.625% (2036) and 5.300% (2055). The Company received approximately $7,431.8 million in net proceeds.
Amphenol intends to use the proceeds, together with cash and potential borrowings, to pay the cash consideration and related fees for its pending acquisition of CommScope’s Connectivity and Cable Solutions businesses. Each series is unsecured, unsubordinated, and ranks equally with other senior debt. If a special mandatory redemption event occurs because the acquisition is not consummated by an agreed date, the notes will be redeemed at 101% of principal plus accrued interest. The notes carry customary covenants and events of default, with stated maturities from 2027 to 2055.
Amphenol (APH): A company officer reported an option exercise and share sale. On 11/05/2025, the VP & Corporate Controller exercised stock options for 120,000 Class A shares at $22 (code M), then sold 120,000 shares at a weighted average price of $140.0517 (code S). Following these transactions, the officer beneficially owns 152,412 shares directly, plus 2,995 indirectly by children and 1,700 indirectly by spouse.
The exercised option covered 120,000 shares, first exercisable on 05/18/2019 and expiring on 05/18/2028, and now shows 0 remaining. The sale price reflects multiple trades ranging from $139.5000 to $140.6225, per the issuer’s note.
Amphenol (APH) received a Rule 144 notice covering a proposed sale of 120,000 common shares. The filing lists Morgan Stanley Smith Barney LLC as broker, with an aggregate market value $16,806,204, to be sold on the NYSE on or about 11/05/2025. Shares outstanding were 1,224,055,508 as of the notice’s disclosure.
The shares to be sold were acquired on 11/05/2025 via an exercise of options under a registered plan for cash. The filing also reports prior sales in the past three months by Michael Ivas: 120,000 shares on 10/31/2025 for $16,956,384, and 50,000 shares on 08/08/2025 for $5,500,820.
Amphenol Corporation (APH): Ownership update. FMR LLC and Abigail P. Johnson filed a Schedule 13G/A reporting beneficial ownership of 99,759,123.18 shares of Amphenol Class A common stock, representing 8.2% of the class as of 09/30/2025.
FMR reported sole voting power over 90,704,832.02 shares and sole dispositive power over 99,759,123.18 shares, with no shared voting or dispositive power. The filing states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.
The filing notes that one or more other persons may have rights to dividends or sale proceeds, but no single person’s interest exceeds five percent of the total outstanding Class A common stock.
APH: A Rule 144 notice was filed for a proposed sale of 120,000 shares of common stock with an aggregate market value of $16,940,472. The filing lists Morgan Stanley Smith Barney LLC as broker, the NYSE as the exchange, and an approximate sale date of 11/03/2025.
The shares to be sold were acquired on 11/03/2025 through the exercise of options under a registered plan, with payment noted as cash. As context, 1,224,055,508 shares were outstanding. In the prior three months, David Silverman sold 100,000 common shares on 08/25/2025 for $11,042,030.
Amphenol (APH): Senior VP, Human Resources reports option exercise and sale. On 11/03/2025, the reporting officer exercised stock options for 120,000 Class A shares at an exercise price of $21.995 per share and sold 120,000 Class A shares at a weighted average price of $141.1706 (executed in multiple trades between $141.00 and $141.50).
Following these transactions, the officer directly beneficially owned 12,500 Class A shares and indirectly owned 14,000 Class A shares through the David Michael Silverman 2025 GRAT #1. Derivative securities beneficially owned following the transactions were 240,000 stock options with an original exercise price of $21.995 and expiration on 05/18/2028.
FAQ
What is the current stock price of Amphenol (APH)?
What is the market cap of Amphenol (APH)?
